REDUCTIONS IN EXACERBATIONS IN PATIENTS WITH ALLERGIC (IGE-MEDIATED) ASTHMA RECEIVING OMALIZUMAB IN A REAL-WORLD SETTING

被引：0
|
作者：
Kuo, H. P. [1 ]
Canvin, J.
Maykut, R. [2 ]
Bruce, J. [2 ]
Chen, C. W. [3 ]
Braunstahl, G. J. [4 ]
机构：
[1] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Taipei, Taiwan
[2] Novartis Pharma AG, Zurich, Switzerland
[3] Novartis Pharmaceut, E Hanover, NJ 07936 USA
[4] St Franciscus Gasthuis, Dept Pulm Med, Gasthuis, Netherlands
来源：
RESPIROLOGY | 2012年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：11 / 11
页数：1
相关论文
共 50 条
  • [1] Reductions in exacerbations with omalizumab in a real-world setting
    Braunstahl, Gert-Jan
    Georgiou, Andreas
    Canvin, Janice
    Maykut, Robert
    Bruce, Jennifer
    Chen, Chien-Wei
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [2] Omalizumab in the management of patients with allergic (IgE-mediated) asthma
    Sandstrom, Thomas
    [J]. JOURNAL OF ASTHMA AND ALLERGY, 2009, 2 : 49 - 62
  • [3] Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma
    Lanier, Bob
    Bridges, Tracy
    Kulus, Marek
    Taylor, Angel Fowler
    Berhane, Indrias
    Vidaurre, Carlos Fernandez
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 124 (06) : 1210 - 1216
  • [4] EFFICACY AND SAFETY OF OMALIZUMAB IN REAL-WORLD CLINICAL PRACTICE IN INDIAN PATIENTS WITH ALLERGIC (IGE-MEDIATED) ASTHMA: ANALYSIS BY BASELINE SEVERITY OF ASTHMA
    Udwadia, Z.
    Narasimhan, R.
    Ratnavelu, V. K.
    Kotnis, M.
    [J]. THORAX, 2013, 68 : A151 - A151
  • [5] Reduction in oral corticosteroid use in patients receiving omalizumab for allergic asthma in the real-world setting
    Braunstahl, Gert-Jan
    Chlumsky, Jan
    Peachey, Guy
    Chen, Chien-Wei
    [J]. ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2013, 9
  • [6] Reduction in oral corticosteroid use in patients receiving omalizumab for allergic asthma in the real-world setting
    Gert-Jan Braunstahl
    Jan Chlumský
    Guy Peachey
    Chien-Wei Chen
    [J]. Allergy, Asthma & Clinical Immunology, 9
  • [7] Real-world outcomes in patients receiving omalizumab for allergic asthma in India: Analysis by baseline IgE level
    Barthwal, Madhusudan
    Dutta, Vijay
    Bhattacharya, Parthasarthi
    Vora, Agam
    Kotnis, Mangala
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [8] Reductions In Oral Corticosteroid Use In Patients With Allergic (IgE- Mediated) Asthma Receiving Omalizumab
    Braunstahl, G.
    Maykut, R.
    Figliomeni, M.
    Chen, C.
    Peachey, G.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB72 - AB72
  • [9] The reduction in asthma exacerbations with omalizumab increases over time in children with severe allergic (IgE-mediated) asthma
    Kulus, M.
    Hebert, J.
    Garcia, E.
    Taylor, A. F.
    Vidaurre, C. F.
    Blogg, M.
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2009, 39 (12): : 1953 - 1953
  • [10] Physician assessment of asthma control in patients receiving omalizumab in a real-world setting
    Szabo, Melinda
    Chlumsky, Jan
    Maykut, Robert
    Georgiou, Panayiotis
    Chen, Chien-Wei
    Peachey, Guy
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2012, 40
12345